DrugPatentWatch

AURYXIA Drug Profile: ferric citrate drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

Out of Stock

ZETONNA Drug Profile: ZETONNA (ciclesonide) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

Out of Stock

NATROBA Drug Profile: NATROBA (spinosad) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

Out of Stock

VIBERZI Drug Profile: VIBERZI (eluxadoline) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

Out of Stock

OSPHENA Drug Profile: OSPHENA (ospemifene) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

Out of Stock

TRULANCE Drug Profile: TRULANCE (plecanatide) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

Out of Stock

EUCRISA Drug Profile: EUCRISA (crisaborole) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

Out of Stock

DYMISTA Drug Profile, 2024: DYMISTA (azelastine hydrochloride; fluticasone propionate) drug patents, FDA exclusivity, litigation, sales revenues

DrugPatentWatch

$209.67

EDARBI Drug Profile, 2024: EDARBI (azilsartan kamedoxomil) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$209.67

MOVANTIK Drug Profile, 2024: MOVANTIK (naloxegol oxalate) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

EDARBYCLOR Drug Profile, 2024: EDARBYCLOR (azilsartan kamedoxomil; chlorthalidone) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$209.67

DIFICID Drug Profile, 2024: DIFICID (fidaxomicin) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$209.67

JENTADUETO XR Drug Profile, 2024: JENTADUETO XR (linagliptin; metformin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

ADVAIR HFA Drug Profile, 2024: ADVAIR HFA (fluticasone propionate; salmeterol xinafoate) drug patents, FDA exclusivity, litigation, drug prices, sale

DrugPatentWatch

$215.57

EXFORGE HCT Drug Profile, 2024: EXFORGE HCT (amlodipine besylate; hydrochlorothiazide; valsartan) drug patents, FDA exclusivity, litigation, drug pric

DrugPatentWatch

$209.67

NAMZARIC Drug Profile, 2024: NAMZARIC (donepezil hydrochloride; memantine hydrochloride) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

BESIVANCE Drug Profile, 2024: BESIVANCE (besifloxacin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$209.67

CORLANOR Drug Profile, 2024: CORLANOR (ivabradine) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$209.67

GLYXAMBI Drug Profile, 2024: GLYXAMBI (empagliflozin; linagliptin) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$209.67

JENTADUETO Drug Profile, 2024: JENTADUETO (linagliptin; metformin hydrochloride) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

BELSOMRA Drug Profile, 2024: BELSOMRA (suvorexant) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$209.67

CRESEMBA Drug Profile, 2024: CRESEMBA (isavuconazonium sulfate) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$209.67

SAVAYSA Drug Profile, 2024: SAVAYSA (edoxaban tosylate) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

OSPHENA Drug Profile, 2024: OSPHENA (ospemifene) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

EPIDUO Drug Profile, 2024: EPIDUO (adapalene; benzoyl peroxide) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

NUCYNTA Drug Profile, 2024: NUCYNTA (tapentadol hydrochloride) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

SANCUSO Drug Profile, 2024: SANCUSO (granisetron) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

VEMLIDY Drug Profile, 2024: VEMLIDY (tenofovir alafenamide fumarate) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32

JANUMET Drug Profile, 2024: JANUMET (metformin hydrochloride; sitagliptin phosphate) drug patents, FDA exclusivity, litigation, drug prices, sales ... Business Intelligence Reports)

DrugPatentWatch

$215.32

NUCYNTA ER Drug Profile, 2024: NUCYNTA ER (tapentadol hydrochloride) drug patents, FDA exclusivity, litigation, drug prices

DrugPatentWatch

$215.32